A biomarker for tracking the progression of ALS

April 4, 2017  At a Glance Researchers discovered that levels of a protein in urine gradually increased in patients with ALS as their disease progressed over 2 years. These results suggest a potential biomarker to monitor disease progress and the effectiveness of therapies. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease in which motor